West Pharmaceutical Services, Inc. (NYSE:WST), a global company involved in innovative solutions for injectable drug administration, announced on Friday that it has received approval from its board of directors for its second-quarter 2023 dividend.
The company has approved a second quarter dividend of USD0.19 per share.
The dividend will be paid to shareholders of record at 26 April 2023 on 3 May 2023.
Danaher Corporation announces quarterly cash dividend
Abbott announces quarterly common dividend
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva